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Enhanced oxidative phosphorylation in NKT cells is
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and Cheong-Hee Changa,1
a
Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI 48109; bImmunology Graduate Program, University
of Michigan Medical School, Ann Arbor, MI 48109; cDepartment of Molecular and Integrative Physiology, University of Michigan Medical School, Ann Arbor,
MI 48109; and dDepartment of Neurology, Henry Ford Health System, Detroit, MI 48202

Cellular metabolism and signaling pathways are key regulators to
determine conventional T cell fate and function, but little is understood
about the role of cell metabolism for natural killer T (NKT) cell survival,
proliferation, and function. We found that NKT cells operate distinct
metabolic programming from CD4 T cells. NKT cells are less efficient
in glucose uptake than CD4 T cells with or without activation. Geneexpression data revealed that, in NKT cells, glucose is preferentially
metabolized by the pentose phosphate pathway and mitochondria,
as opposed to being converted into lactate. In fact, glucose is essential for the effector functions of NKT cells and a high lactate environment is detrimental for NKT cell survival and proliferation. Increased
glucose uptake and IFN-γ expression in NKT cells is inversely correlated with bacterial loads in response to bacterial infection, further
supporting the significance of glucose metabolism for NKT cell function. We also found that promyelocytic leukemia zinc finger seemed
to play a role in regulating NKT cells’ glucose metabolism. Overall,
our study reveals that NKT cells use distinct arms of glucose metabolism
for their survival and function.
NKT
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nvariant natural killer T (NKT) cells are lymphocytes sharing
characteristics of innate and adaptive immune cells and acting
as a bridge between the two immune responses. The hallmark of
NKT cells is their ability to produce a copious amount of
proinflammatory and immune modulatory cytokines very rapidly
after antigenic stimulation (1, 2). NKT cells are CD1d-restricted
T cells that respond to a variety of glycolipids (3). These cells
express a highly restricted T cell receptor (TCR) repertoire and
develop in the thymus from a common precursor of CD4 CD8
double-positive thymocytes (4). Compared with conventional
T cells, NKT cells require distinct signaling for development in
the thymus (5, 6). NKT cells develop to produce IFN-γ, IL-4, and
IL-17, designated as NKT1, NKT2, and NKT17 subsets, respectively,
which can be distinguished based on the expression of the
transcription factors promyelocytic leukemia zinc finger (PLZF),
T-bet, and RORγt (7–9). In the peripheral organs like liver,
spleen, lymph node, and adipose tissue, NKT cells differentiate
further and gain specific functional characteristics to become
proinflammatory or immunomodulatory (10). Thus, NKT cells
are a heterogeneous population that show a high degree of phenotypic and functional specialization and their role in autoimmune
diseases (11, 12), infectious diseases (13–15), asthma (16), and
antitumor immune responses in both experimental models and
humans (10, 17–19) has been well established.
PLZF (encoded by Zbtb16) is a BTB-zinc finger transcription
factor expressed by innate-like T cells, including NKT cells but
not by conventional T cells or NK cells (20, 21). PLZF regulates
early developmental and functional differentiation of NKT cells.
Zbtb16 mutation or deletion leads to abrogation of expansion
and effector-memory differentiation of NKT cells, resulting in reversal to a naive phenotype (22). Similarly, the ectopic expression of
PLZF in CD4 T cells induces the phenotype and functions similar
www.pnas.org/cgi/doi/10.1073/pnas.1901376116

to those of NKT cells (21, 23). We have recently shown that PLZF
also regulates the level of reactive oxygen species (ROS) in NKT
cells, suggesting its role in cellular metabolism in NKT cells (24).
The signaling pathways that control cellular metabolism play a
critical role in dictating the outcome of T cell activation and
effector functions (25–30). Antigen-dependent T cell activation
triggers the PI3K pathway and subsequently activates the mammalian target of rapamycin (mTOR) complex 1 (C1) and complex
2 (C2) (31). mTORC1, a serine-threonine kinase, integrates various
environmental cues and regulates cell growth, cell proliferation, and
metabolism (31). mTORC1 and mTORC2 deletions lead to
defective NKT cell development at an early stage and impair
their functions (5, 6, 32). Additionally, myelocytomatosis oncogene (c-myc), which is downstream of mTORC1, has been shown
to play a role in early NKT cell development and in progression
beyond the immature NKT stage (33, 34). Furthermore, unlike
CD4 T cells, NKT cells are sensitive to changes in signaling
pathways mediated by CD28 (35), ICOS (36), PI3K (37, 38), and
Wnt/β-Catenin (39); most of them are known to regulate the
metabolic pathways.
Upon activation, T cells proliferate and increase their biomass
for which they not only require an increased amount of energy
but also need to facilitate nutrient uptake for the generation of
daughter cells (40). To fulfill these high demands of activated
cells, T cell metabolism is reprogramming from preferentially
utilizing OXPHOSto glycolysis (27, 41). Glycolysis produces biosynthetic
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incubated with 2-NBDG for different time periods. NKT cells again
showed lower glucose uptake compared with CD4 T cells (Fig. 1B).
To further elucidate whether this difference in glucose uptake at
the steady state is due to a different expression level of a glucose
transporter, we measured the surface expression of Glut1, a major
glucose transporter in T cells (47). The expression of Glut1 was
significantly lower in NKT cells compared with CD4 T cells (Fig.
1C), suggesting that low glucose uptake is likely due to low Glut1
expression. T cell activation and their subsequent phenotypic
adaptation into different effector states are characterized by
distinct metabolic pathways (25, 26). Therefore, we further investigated the glucose uptake in response to activation of NKT cells. In
vivo activation of NKT cells by anti-CD3 antibody led to an increase
in their glucose uptake but the levels were still lower compared with
activated CD4 T cells (Fig. 1D). Altogether, these data indicate that
NKT cells have lower potential for glucose uptake at steady-state and
after activation compared with CD4 T cells.

materials to support proliferation and this shift regulates the
acquisition of effector function in certain T cell subsets (25, 42).
Despite the fact that activated T cells primarily use glycolysis,
mitochondrial metabolism is also important for T cell activation
(43). Decreasing the metabolic rate in T cells leads to immunological anergy that is associated with diminished cytokine
production, growth, and proliferation (44, 45).
In contrast to classic T cells, little is known about the metabolic
needs of NKT cells. A study has shown that during thymic development, NKT cells increase glucose uptake and expression of
glucose transporter 1 (Glut1) at stages 0 and 1, the highly proliferating cells, but decreases subsequently at stages 2 and 3, the
low proliferating cells (46). Recently, we have shown that
NKT cells have lower mitochondrial ROS during steady state
than CD4 T cells, suggesting distinct metabolic requirements in
NKT cells (24). However, none of these studies have yet demonstrated a succinct overview of cellular metabolism in NKT cells.
In the present study, we report that resting NKT cells are less
efficient in glucose uptake than resting CD4 T cells. Even after
activation, NKT cells remain less glycolytic than CD4 T cells and
rely more on oxidative phosphorylation (OXPHOS) for their
survival, and the repurposed glucose carbon is used for optimal
cytokine expression. Furthermore, we demonstrated that high
lactate environment is detrimental for NKT cell growth and
homeostasis. Finally, PLZF correlates negatively with glycolytic
potential in NKT cells. Taken together, these data show tht
distinct cellular metabolism governs NKT cells’ homeostasis and
immune functions.

Limiting Glucose Reduces the Cytokine Expression of NKT Cells. Our
observation that NKT cells have increased glucose uptake after
activation indicates that NKT cells might use glucose for cellular
functions triggered as a result of activation. To determine the
importance of glucose for the survival, proliferation, and function of NKT cells, we sorted NKT cells and stimulated them with
α-Galactosylceramide (α-GalCer) for 3 d in media containing
different concentrations of glucose. Of note, when NKT cells were
stimulated with anti-CD3 and anti-CD28 antibodies that were used
to stimulate CD4 T cells, we observed similar responses by the two
stimulation methods (SI Appendix, Fig. S1). Therefore, we used
both stimulation methods interchangeably. We found that NKT cell
survival was comparable regardless of glucose concentration (Fig.
2A). Furthermore, NKT cell proliferation was not affected by low
concentrations of glucose, although their cell division was slightly
reduced in media without glucose (Fig. 2B, Left). In contrast to
NKT cells, CD4 T cells were much more sensitive to glucose deficiency for their proliferation (Fig. 2B, Right). We also tested the
responses of both cell types by treating cells with an inhibitor of
glucose metabolism, 2-deoxyglucose (2-DG). NKT cell survival was
not significantly different but proliferation was inhibited by 2-DG
treatment (SI Appendix, Fig. S2A). It is likely that NKT cells rely on
glucose for proliferation, which is inhibited by 2-DG. In the absence
of glucose, however, NKT cells switch their metabolic preference
and are able to proliferate.

Results
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Fig. 1. NKT cells take up glucose less efficiently than
CD4 T cells. (A) Representative histogram comparing
in vivo glucose uptake in NKT and CD4 T cells from
C57BL/6 mice injected with 100 μL of 2-NBDG (12.5-mg/g
body weight) intravenously. The graph shows cumulative of four independent experiments. (B) The representative histograms show comparative glucose
uptake between NKT and CD4 T cells. Freshly isolated
splenocytes from C57BL/6 mice were incubated with
2-NBDG (20 μM) in glucose-free media for indicated
time periods. The graph is cumulative of three independent experiments. (C) The histogram represents
Glut1 expression between NKT and CD4 T cells from
total splenocytes. The graph is cumulative of four independent experiments. (D) C57BL/6 mice were injected
intraperitoneally with 100 μL of anti-CD3 antibody
(2.5-mg/g body weight) 20–22 h before the intravenous injection of 2-NBDG, as mentioned in A. The
representative histogram shows glucose uptake in
NKT and CD4 T cells. The graph is cumulative of three
independent experiments. Error bars represent mean ±
SEM; *P < 0.05, **P < 0.01.
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These observations prompted us to test if NKT cells use glutamine as a source of energy for their survival similar to CD4
T cells (48, 49). Sorted NKT cells were stimulated in the presence of either glucose or glutamine alone and compared with
media containing both. Cell survival and proliferation were
drastically reduced with glutamine deprivation compared with
glucose deficiency, suggesting that glutamine is a critical carbon
source for NKT cell survival and proliferation (Fig. 2C and SI
Appendix, Fig. S2B). Although our data revealed an essential role
of glutamine for NKT cell proliferation, the present study focuses on glucose metabolism because little is known about how
NKT cells utilize glucose.
Glycolysis supports cytokine production in CD4 T cells (50).
Therefore, we asked if glucose is necessary for cytokine production in NKT cells. We found that NKT cells displayed a dosedependent decrease in IL-4+, IFN-γ+, and IL-17+ NKT cells
under glucose-limiting conditions (Fig. 2D). To test the response
of NKT cells to glucose deprivation and replenishment, we
stimulated them without glucose for 3 d and then added glucose
during the PMA/ionomycin restimulation step. While glucose
depletion for 3 d reduced the frequency of NKT cells expressing
IL-4, IFN-γ, and IL-17, replenishment with glucose for 4 h increased
the levels of all cytokines (SI Appendix, Fig. S2C). Similarly, we
investigated the role of glucose for the expression of cytokines in
freshly isolated NKT cells by stimulating them with PMA/ionomycin
for 4 h in the presence or absence of glucose. In the absence of
glucose, the frequency of IFN-γ+ NKT cells was reduced (SI
Appendix, Fig. S2D). In conclusion, glucose is indispensable for
cytokine production by NKT cells but is less significant for either
their survival or proliferation.
In Vivo Immune Response of NKT Cells to Bacterial Infection Correlates
with Glucose Uptake. NKT cells constitute an important component

of the innate immune response to Listeria monocytogenes infection
(51). To understand the functional significance of glucose metabolism in NKT cells in response to bacterial infection, we infected
C57BL/6 mice with two different doses (105 and 107 CFU per
mouse) of L. monocytogenes. Two days after infection, we analyzed
bacterial loads as well as glucose uptake and IFN-γ expression in
Kumar et al.

Fig. 2. Glucose is essential for optimal cytokine expression but not for survival and proliferation of
NKT cells. (A) NKT cells were sorted from spleens of
C57BL/6 mice and stimulated with α-GalCer (100 ng/mL)
in the presence of indicated concentrations of glucose
in the media. The graph shows the percentage of live
NKT cells on day 3 of stimulation measured by PI exclusion (n = 3). (B) NKT and CD4 T cells were sorted,
labeled with CellTrace Violet and then stimulated in
the indicated concentrations of glucose-containing
media. α-GalCer or anti-CD3 with anti-CD28 antibodies
(details are described in Materials and Methods) were
used to stimulate NKT or CD4 T cells, respectively. Representative histograms show cell proliferation measured
after 3 d of stimulation. (C) Sorted NKT cells were
stimulated as in A in the presence of 10 mM glucose
or 2 mM glutamine alone, or with both in the media.
The graph shows the fold-change in percent of live
NKT cells after 3 d (n = 3). (D) Representative plots
show cytokine expression in NKT cells stimulated for
3 d in the indicated glucose concentrations and restimulated with PMA and ionomycin in the same media conditions. Error bars represent mean ± SEM; *P < 0.05.

splenic NKT cells. As expected, the mice infected with a higher
dose of bacteria showed more bacterial titers in the spleen than
those infected with the lower dose (Fig. 3A). In response to bacterial infection, glucose uptake by NKT cells was negatively correlated with bacterial growth (Fig. 3B). We also observed that the
higher the glucose uptake, the more IFN-γ expressing NKT cells
(Fig. 3C, Left). In addition, the amount of IFN-γ per cell, reflected
by mean fluorescence intensity (MFI) values, was higher with increased glucose uptake (Fig. 3C, Right). Additionaly, data showed
that increased expression of IFN-γ by NKT cells led to suppression
of bacterial growth (Fig. 3D). Taken together, these observations
suggest that, upon bacterial infection, the cytokine production of
NKT cells is regulated by glucose consistent with the data shown in
Fig. 2.
Increased Glucose Uptake upon TCR Stimulation in NKT Cells Is Mediated
by mTORC. mTORC regulates various cellular aspects of metabolism

and is involved in TCR activation-mediated induction of glucose
uptake and glycolysis (31). Thus, we first assessed if the mTORC1
and mTORC2 activities are increased in NKT cells upon activation
by measuring the expression of pS6Ser235/236 and pAktSer473, respectively. The level of phosphorylation of both molecules increased
progressively at day 1 and day 3 of stimulation over day 0, demonstrating increased mTORC1 and mTORC2 signaling activity in
NKT cells upon activation (Fig. 4A). Furthermore, compared with
CD4 T cells, NKT cells have a higher mTORC1 expression on day
3 of stimulation (SI Appendix, Fig. S3A).
Having observed that glucose uptake and mTORC activity are
increased in NKT cells upon stimulation, we investigated if mTORC
signaling regulates glucose uptake in these cells. For this, we treated
NKT cells with rapamycin during stimulation. Rapamycin treatment
decreased the level of pS6Ser235/236 and pAktSer473, confirming mTORC1
and mTORC2 inhibition, respectively (Fig. 4B, Upper). Data
showed that rapamycin treatment decreased the glucose uptake
in NKT cells, which was accompanied by decreased cell size as
evidenced by lower FSC in the rapamycin-treated NKT cells than
control cells (Fig. 4B, Lower). Therefore, mTORC activity is
required for optimal glucose uptake and subsequently for proper
cell growth of NKT cells. One of the main functions of mTORC
PNAS | April 9, 2019 | vol. 116 | no. 15 | 7441
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Fig. 3. Glucose uptake of NKT cells correlates with their function in response to bacterial infection. A group of C57BL/6 mice (four to five mice per
group) were infected with 105 or 107 CFU per mouse LM-Ova intraperitoneally. Two days after infection, spleens were used for bacterial enumeration, 2-NBDG uptake, and IFN-γ expression. (A) Bacterial loads in the spleens
of mice that were infected with the two different doses of Listeria are
shown. (B) Glucose uptake measured by 2-NBDG inversely correlates with the
bacterial loads. The 2-NBDG uptake assay was performed using freshly isolated splenocytes from infected mice. (C and D) Total splenocytes were incubated in the presence of Golgi Plug for 2 h followed by intracellular
cytokine staining for IFN-γ expression in NKT cells. The frequency of IFN-γ+
(L) as well as the MFI of IFN-γ+ (Right) NKT cells show a positive and negative
correlation with glucose uptake (C) and bacterial loads (D), respectively. Two
independent experiments showed similar results. Spearman correlation was
used for correlation calculation.

activity is to regulate cell proliferation (45). We also found that
mTORC inhibition affected cell proliferation of NKT cells more
severely compared with CD4 T cells (Fig. 4C). Moreover, the
frequencies of IL-4+, IFN-γ+, and IL-17+ NKT cells were decreased
when mTORC was inhibited (SI Appendix, Fig. S3B), supporting
the earlier studies showing that mTORC activity is important for
effector functions of NKT cells (5). In summary, these data
demonstrate that mTORC up-regulates glucose uptake, which in
turn controls NKT cell growth upon activation.
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NKT Cells Primarily Use OXPHOS for Their Survival, Proliferation, and
Selective Cytokine Production. To gain a better understanding of

metabolism in NKT cells, we next used liquid chromatography
(LC) -coupled tandem mass spectrometry (LC-MS/MS)–based
metabolomics approaches. We observed a higher level of glucose
6-phosphate (G6P) but lower levels of other metabolites from
glycolysis in NKT cells compared with CD4 T cells (Fig. 5A).
Levels of metabolites from the TCA cycle were comparable between
NKT and CD4 T cells (SI Appendix, Fig. S4A). These data
support the observation that glycolytic activity is lower in NKT
than CD4 T cells. We also compared the expression of genes
7442 | www.pnas.org/cgi/doi/10.1073/pnas.1901376116

encoding key enzymes involved in these metabolic pathways
between NKT and CD4 T cells. The first rate-limiting enzymatic
gene of glycolysis, hexokinase 2 (Hk2), was up-regulated in NKT
cells compared with CD4 T cells before stimulation supporting
the increase of G6P (SI Appendix, Fig. S4B and Table S1). Expression of downstream enzyme genes was lower in NKT than CD4
T cells. Stimulated NKT cells showed a similar pattern by greatly
inducing Hk2 expression but not other genes encoding enzymes
leading to the glycolytic pathway (Fig. 5B, Left). In contrast, the genes
involved in the pentose phosphate pathway (PPP) were up-regulated in
NKT cells compared with CD4 T cells after activation (Fig. 5B, Center,
and SI Appendix, Table S1). These results suggest that G6P is differentially funneled into the PPP in NKT cells relative to CD4 T cells.
Pyruvate dehydrogenase kinases (Pdk1 and Pdk2) phosphorylate
and negatively inhibit the activity of the pyruvate dehydrogenase
(Pdh) complex, which oxidizes pyruvate and channels it into the
TCA cycle. Pdk1 and Pdk2 were down-regulated in NKT cells,
whereas Pdh genes (Pdha1 and Pdhb) were highly increased,
suggesting that NKT cells oxidize pyruvate in the mitochondria
to a greater degree than do CD4 T cells (Fig. 5B, Left, and SI
Appendix, Table S1). These observations were further supported
by higher levels of TCA cycle enzymatic gene expression in
NKT cells than in CD4 T cells (Fig. 5B, Right, and SI Appendix,
Table S1). To further confirm the low glycolytic potential of
NKT cells, we measured the intracellular lactate level in NKT
and CD4 T cells with or without activation. We observed similar
levels of intracellular lactate in freshly isolated NKT and CD4
T cells (Fig. 5C). After activation, lactate levels were increased in
NKT and CD4 T cells, but the levels were lower in NKT cells
than CD4 T cells (Fig. 5C). Finally, consistent with no known
role for gluconeogenesis or glycogen metabolism in T cells, genes
in these pathways were not altered in NKT cells upon activation
(SI Appendix, Table S1). Based on this summation of data, we conclude that glucose carbon is differentially directed to the PPP and TCA
cycle in NKT cells, relative to CD4 T cells (SI Appendix, Fig. S4C).
Low intracellular levels of lactate and high expression of TCA
cycle genes led us to hypothesize that NKT cells rely on OXPHOS
instead of glycolysis for their survival and homeostasis. Because
mitochondria are best known for their role as energy powerhouses,
we speculated that NKT cells generate high amounts of ATP. Indeed, NKT cells had higher amounts of intracellular ATP compared
with CD4 T cells both before and after stimulation, suggesting higher
OXPHOS in NKT cells (Fig. 5D). Because OXPHOS occurs in the
mitochondria, we studied the mitochondrial activity in NKT cells.
Activated NKT cells showed increased mitochondrial mass and
mitochondrial function as measured by MitoTracker and tetramethylrhodamine methyl ester perchlorate (TMRM), respectively,
relative to CD4 T cells (Fig. 5 E and F).
To further investigate the role of mitochondrial OXPHOS in
NKT cell metabolism, we activated NKT cells in the presence or
absence of oligomycin for 3 d. Oligomycin targets ATP synthase,
leading to inhibition of electron flow through the electron transport
chain and stopping respiration (50). NKT cell survival was decreased in the presence of oligomycin, indicating that, unlike CD4
T cells, they cannot readily switch to generating ATP from glycolysis
(Fig. 5G). NKT cell proliferation was also reduced with oligomycin
treatment (Fig. 5H). The frequencies of IL-4+ and IL-17+ NKT cells
were also decreased in the presence of oligomycin (SI Appendix, Fig.
S4D). Therefore, OXPHOS seems to be critical for NKT cell survival
and proliferation, as well as for optimal cytokine production.
High Lactate Microenvironment Is Detrimental for NKT Cell Homeostasis
and Their Effector Function. Because conventional T cells are resistant

to high lactate environment-mediated cell apoptosis (52), we asked if
the less glycolytic NKT cells would be more sensitive to increased
extracellular lactate. To test this, we cultured NKT cells in the presence
of sodium lactate (20 mM and 40 mM) or sodium chloride, and then
measured NKT cell survival, proliferation, and cell size. The data
Kumar et al.
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showed that high lactate exerted a negative effect on survival, proliferation, and cell size of NKT cells (Fig. 6 A–C), while high lactate
increased the size of CD4 T cells (Fig. 6C, Right). In addition, high
lactate reduced mTORC activity, as evidenced by the reduced level of
pS6Ser235/236 in NKT but not in CD4 T cells (Fig. 6D). High-lactate
environment also reduced the frequencies of IL-4+ and IL-17+ but
not IFN-γ+ NKT cells, suggesting that cytokine functions of NKT
cells are altered in a high-lactate environment (Fig. 6E). Taken
together, the data suggest that a low level of lactate in NKT cells is
important for their homeostasis and optimal cytokine expression.
PLZF Correlates with Low Glycolysis in NKT Cells. Previously, we have
shown that PLZF controls the level of ROS in NKT cells (24),
indicating that it might play a role in the metabolism of NKT
cells. To test this, we used two approaches. First, we examined
NKT cells from PLZF haplodeficient (PLZF+/−) mice. Because
PLZF−/− mice are devoid of NKT cells, these mice are not suitable
for the study (20). We observed that the percentages of 2-NBDGhi
and Glut1-expressing NKT cells were significantly increased in
PLZF+/− mice compared with the WT mice (Fig. 7A). In addition,
the intracellular lactate levels, mitochondrial ROS, mitochondrial
mass, and mitochondrial potential were increased in PLZF+/−
NKT cells compared with WT NKT cells (Fig. 7B and SI Appendix,
S5A). Next, we asked if PLZF expression is sufficient to reduce
glucose uptake and subsequent processes. CD4 T cells from mice
expressing the PLZF transgene (PLZFTg) showed reduction of both
the frequency of 2-NBDGhi cells and the Glut1-expressing cells
(Fig. 7C). Activated PLZFTg and WT CD4 T cells, however, had
similar levels of glucose uptake and Glut1 expression (SI Appendix,
Fig. S5B). To test if PLZF levels affect glycolysis, we measured
intracellular lactate levels and found significantly lower lactate
levels in PLZFTg than WT CD4 T cells (Fig. 7D, Upper). We also
found that ATP levels were significantly higher in PLZFTg than WT
CD4 T cells (Fig. 7D, Lower), indicating that CD4 T cells expressing
PLZF have increased mitochondrial activity.
To further study PLZF-mediated metabolic changes, we used
the Seahorse bioanalyzer to analyze the rate of glycolysis by
measuring extracellular acidification rate (ECAR). In this experiment, we used WT and PLZFTg CD4 T cells because it is
challenging to get a sufficient number of NKT cells for this assay.
Moreover, PLZFTg CD4 T cells share similar metabolic characteristics to NKT cells (Fig. 7). In line with low intracellular
lactate level, ECAR was lower in CD4 T cells from PLZFTg
compared with WT mice (Fig. 8A). Thus, expression of PLZF
reduced the rate of glycolysis. Glucose is a major carbon source
for the TCA cycle. To test its utilization in a PLZF-dependent
manner, we traced glucose carbon incorporation into TCA cycle
Kumar et al.
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Fig. 4. mTORC regulates glucose uptake in activated
NKT cells. (A) NKT cells were sorted from spleens of
C57BL/6 mice and stimulated with anti-CD3 and antiCD28 antibodies. Representative histograms from
three independent experiments show the level of
pS6Ser235/236 and pAktSer473 in NKT cells at day 0 (D0),
day 1 (D1), and day 3 (D3) of stimulation. (B) Sorted
NKT cells were stimulated for 3 d with α-GalCer in the
presence of either DMSO (Control) or rapamycin
(20 nM). Representative histograms show the amounts
of pS6Ser235/236, pAktSer473, 2-NBDG uptake (20 μM), and
FSC of NKT cells on day 3. (C) NKT cells were stimulated
as mentioned in B and CD4 T cells as described in
Materials and Methods in the presence of rapamycin
(2 nM and 20 nM) or DMSO for 3 d. Cell proliferation
was measured using CellTrace Violet dilutions. Histograms are representative of at least three independent
experiments.

intermediates using nonradioactive carbon-13 isotope labeled
glucose ([U-13C]-glucose) and LC/MS-based metabolomics in
PLZFTg and WT CD4 T cells for 4 h. PLZFTg CD4 T cells exhibited
a lower abundance of glucose-derived 13C3-phosphoglycerate (2-PG)
(m+3) and 13C3-lactate (m+3) (Fig. 8B), further illustrating that
PLZF limits glycolytic flux. Furthermore, we found that PLZFTg
CD4 T cells had a higher abundance of glucose-derived 13C2-citrate
(m+2) compared with WT CD4 T cells, indicating a greater diversion of glucose-derived pyruvate into the TCA cycle (Fig. 8B).
However, the abundance of glucose-derived 13C2-succinate (m+2)
and 13C2-malate (m+2) were similar in WT and PLZFTg CD4
T cells (Fig. 8B). These results suggest that, in the PLZFTg CD4
T cells, glucose-derived carbon preferentially enters the TCA cycle
to make citrate, and that other carbon sources also contribute to
TCA cycle anaplerosis. Based on the results in Fig. 2, this is likely
accounted for by glutamine-derived carbon.
Discussion
The metabolic demands of naïve T cells are lower because they
require energy only for survival, cell migration, and preventing
atrophy. This demand increases in activated T cells, which requires energy for rapid growth, proliferation, and production of
effector molecules (53). Thus, it is essential for T cells to switch
their cellular metabolism to meet the biosynthetic needs of the
cells. NKT cells are different from conventional T cells in that
they are able to rapidly elicit effector functions in response to
activation. As such, understanding the metabolic programming
of NKT cells was the primary goal of this study. Here, we report
that NKT cells in the resting state use less glucose than conventional
CD4 T cells, suggesting that these cells are metabolically quiescent,
like memory T cells (54). Due to the marked disparity in the energy
requirement of resting versus activated T cells, regulation of glucose
uptake is considerably different. In the resting state, glucose
uptake is not regulated through TCR-mediated activation signals. On the other hand, activation of TCR-mediated signaling
increases surface expression of key nutrient receptors and cellular
metabolism (55). The present study showed that activated NKT cells
up-regulate the surface expression of the glucose transporter Glut1
and increase their glucose uptake. However, activated NKT cells are
still less efficient than activated CD4 T cells in their glucose uptake.
T cells switch metabolism from OXPHOS to glycolysis for
their proliferation and effector functions as soon as they are
activated (56). A previous study indicated that glycolysis affects
the translation of cytokines at the posttranscriptional level (50).
In agreement, our data show that glucose is required for proper
expression of cytokines by NKT cells. This observation is further
corroborated by the fact that the effect of 3 d of starvation on
PNAS | April 9, 2019 | vol. 116 | no. 15 | 7443
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Fig. 5. Maintenance of optimum NKT cell survival, proliferation and function requires elevated OXPHOS. (A) Freshly sorted NKT and CD4 T cells from C57BL/
6 mice were subjected to metabolomic analysis through LC-MS/MS. The graph shows relative levels of metabolites representing glycolysis between NKT and
CD4 T cells. Values are from three replicas. (B) Sorted NKT and CD4 T cells were stimulated with anti-CD3 and anti-CD28 antibodies for 3 d, and RNA was
prepared. Expression of genes involved in the indicated pathways of glucose metabolism was measured using RT2 PCR array. Fold-change was calculated as
described in Materials and Methods and the values were compared between stimulated NKT and CD4 T cells. The graphs are cumulative of three independent
experiments. (C and D) The graphs show intracellular levels of lactate (C) and ATP (D) in NKT and CD4 T cells with (D3) or without (D0) stimulation with antiCD3 and anti-CD28 antibodies for 3 d. (E and F) Representative histograms show mitochondrial mass measured by staining with MitoTracker (E) and mitochondrial potential measured by TMRM staining (F) in NKT and CD4 T cells without (D0) and with stimulation (D3), as mentioned in B. The graphs are
cumulative of three to four experiments. (G and H) Sorted NKT and CD4 T cells were stimulated with α-GalCer and anti-CD3 and anti-CD28 antibodies, respectively, in the presence of DMSO (0 mM) or oligomycin at indicated concentrations. (G) The graph shows fold-changes in percent live NKT and CD4 T cells
measured by PI exclusion after 3 d of stimulation in the presence of 10 nM oligomycin (n = 3). (H) Representative histograms show NKT cell proliferation
measured using CellTrace Violet dilutions on day 3 of stimulation of NKT cells. All of the results are representative of at least three independent experiments.
Error bars represent mean ± SEM; *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.

cytokine synthesis in NKT cells was reversed by replenishment of
glucose for 4 h during PMA/ionomycin restimulation. These
findings were also supported by our in vivo infection data, which
showed that glucose uptake was directly correlated with cytokine
production in NKT cells in response to the bacterial infection.
Furthermore, NKT cells with high glucose uptake suppressed the
bacterial growth more efficiently. However, glucose does not
seem to be necessary for NKT cell proliferation. Instead, we
found that glutamine is an essential carbon source for NKT cells’
survival and proliferation, and further investigation of glutamine
metabolism in NKT cells is warranted.
Recently, metabolic regulators, such as Folliculin-interacting
protein 1 (Fnip1), mTORC1, mTORC2, and c-myc have been
shown to regulate NKT cell development, suggesting a possible
role of signaling molecules in regulating metabolism in NKT
cells (5, 6, 33, 57). mTORC is activated in response to signals
7444 | www.pnas.org/cgi/doi/10.1073/pnas.1901376116

from extracellular growth factors, nutrient availability, and the
energy status of T cells. mTORC1 regulates various aspects of
cellular metabolism, including glycolysis, protein synthesis, and
lipid synthesis. mTORC1 regulates glycolysis through hypoxiainducible factor-1α (HIF-1α) and c-myc (58, 59). These transcription
factors control the expression of glucose transporters and multiple enzymes controlling glycolysis. Both the mTORC1 target
pS6Ser235/236 and the mTORC2 target pAktSer473 were induced in
activated NKT cells, and blocking these signals by rapamycin treatment decreased glucose uptake. The fact that the effects of mTORC
inhibition are more severe than glucose depletion during stimulation
suggests that NKT cells rely more on other metabolic pathways
controlled by mTORC than glycolysis. NKT cell proliferation
was more sensitive to rapamycin treatment than CD4 T cells,
which could be explained by higher mTORC activity in NKT
than CD4 T cells after 3 d of stimulation.
Kumar et al.
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Fig. 6. A high-lactate environment is detrimental for NKT cell homeostasis and effector functions. Sorted NKT and CD4 T cells from of C57BL/6 spleens were
stimulated for 3 d, as in Fig. 2, in the presence of NaCl or Na-lactate. (A) The graph shows fold-changes in surviving NKT cells under the indicated conditions at
day 3 using PI exclusion assay (n = 3). (B) Representative histograms show proliferation of NaCl and Na-lactate (20 mM and 40 mM) treated NKT cells using
CellTrace Violet dilutions (n = 3). (C and D) Representative histograms comparing the cell size measured using FSC (C) and levels of pS6Ser235/236 (D) in NKT and
CD4 T cells treated with NaCl and Na-lactate (40 mM) (n = 3). (E) Representative plots show the cytokine expressions in NKT cells stimulated for 3 d in the
presence of either NaCl or Na-lactate (40 mM) and restimulated with PMA and ionomycin on day 3. Summary graphs on the Right show percentages of IL-4+
and IL-17+ NKT cells. All of the data are representative of at least three independent experiments. Error bars represent mean ± SEM; *P < 0.05.

The results from metabolomic and gene-expression analyses
for glucose metabolism demonstrated differences between NKT
and CD4 T cells. NKT cells have lower levels of glycolytic metabolites
in the steady state. Unlike CD4 T cells, activation of NKT cells
substantially increased the expression of genes encoding enzymes
involved in the PPP and the TCA cycle. Pdk increases the oxidation of pyruvate, the end product of glycolysis into lactate by
inhibiting the activity of Pdha, the enzyme responsible for oxidizing pyruvate into acetyl-CoA in the mitochondria (60). NKT
cells expressed reduced Pdk1 but increased Pdha1 genes, suggesting that pyruvate may be primarily converting into acetylCoA and then enters the mitochondria rather than converting
into lactate. This was further corroborated by the finding of
lower levels of intracellular lactate in NKT cells than CD4 T cells
upon activation. High levels of lactate in the extracellular environment decreased mTORC signaling activity, which was detrimental
for NKT cell survival but favorable for CD4 T cells. In addition,
NKT cells reduced IL-4 and IL-17 production but not IFN-γ production, suggesting that IFN-γ expression is more resistant to cellular
stress caused by high lactate. In contrast to this, CD4 T cells produce
more IL-17 and less IFN-γ in high lactate environment (61).
In this study, we observed that the level of PLZF correlates
with the glycolysis rate in NKT cells. PLZF suppresses the initiation of c-myc transcription in non-T cells (62). C-myc controls
not only key cell cycle regulators, but also is responsible for the
metabolic switch from OXPHOS to glycolysis in T cells upon
activation (59). It is possible that the decreased glucose uptake
that we observed in NKT cells is a consequence of low c-myc
expression. PLZF is known to suppress mTORC1 activity by
Kumar et al.

inducing expression of the mTORC1 inhibitor Redd1 in stem
cells (63). In contrast to an earlier study showing that PLZF
overexpression in brown adipose tissue increases mitochondrial
respiration (64), we observed reduced mitochondrial mass and
potential in PLZFTg CD4 T cells. The difference is likely due to
the cell type-specific function of PLZF. Additionally, we provided supporting evidence that glucose is oxidized in the mitochondria as glucose-derived citrate levels are higher in PLZFTg
than WT CD4 T cells. However, this citrate might be metabolizing in the fatty acid synthesis pathway instead of circulating in
the TCA cycle, as revealed by similar levels of abundance of 13
C2-succinate and malate. It should be noted that due to the
limited number of NKT cells, metabolic assays requiring a high
number of cells were performed with PLZFTg CD4 T cells as a
model to study the role of PLZF. Nevertheless, the data from
PLZF+/− NKT cells align with PLZFTg CD4 T cells, supporting
the idea that PLZF might regulate low glycolysis in NKT cells.
To investigate how PLZF regulates these metabolic differences,
we reanalyzed the ChIP-sequencing data of NKT and PLZFTg
thymic cells (GSE81772) archived in databases (22). The analysis
showed that PLZF does not seem to bind to genes involved in glucose
metabolism that expressed higher or lower levels in NKT cells than
CD4 T cells before stimulation (SI Appendix, Fig. S6). Therefore, the
data suggest an indirect role of PLZF in glucose metabolism.
However, we cannot rule out the possibility that PLZF’s binding
could be changed in stimulated NKT cells. Unfortunately, this
type of experiment is highly challenging to do with stimulated
NKT cells due to the limited cell number. Therefore, further
PNAS | April 9, 2019 | vol. 116 | no. 15 | 7445
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Fig. 7. PLZF levels negatively correlate with glycolysis rate in NKT and PLZFTg CD4 T cells. (A) Representative histograms show 2-NBDG uptake (Upper) and
Glut1 expression (Lower) in splenic NKT cells from PLZF haplodeficient (+/−) and WT littermate (+/+) mice. The graphs (Right) are cumulative of four independent experiments. (B) The graph shows intracellular lactate levels in freshly sorted NKT cells from PLZF haplodeficient (+/−) and WT littermate mice (n =
3). (C) Representative histograms compare 2-NBDG uptake (Upper) and Glut1 expression (Lower) in splenic CD4 T cells from PLZFTg (Tg) and WT littermate
mice. The bar graphs are cumulative of four independent experiments. (D) The graphs show intracellular lactate (Upper) and ATP levels (Lower) in enriched
CD4 T cells from PLZFTg and WT littermate mice before (D0) and after 3 d of stimulation (D3) with anti-CD3 and anti-CD28 antibodies. The graphs are cumulative of three independent experiments. Error bars represent mean ± SEM; *P < 0.05, **P < 0.01, ***P < 0.001.

mechanistic studies are warranted to understand how PLZF
controls the metabolic activity in NKT cells.
In summary, the present study shows that NKT cells rely primarily
on OXPHOS for their survival and proliferation. When NKT cells
encounter antigen, they up-regulate mTORC signaling and glycolysis,
both of which are important for proper cytokine expression.
Materials and Methods
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Mice. Male and female mice at 8–12 wk of age on the C57BL/6 background
were used in this study. Mice were purchased from Jackson Laboratories and
housed in specific pathogen-free conditions. PLZF transgenic (referred to as
PLZFTg) mice driven by the lck promoter (23) and PLZF-haplodeficient mice
(referred to as PLZF+/−) (65) have been kindly provided by Derek Sant’Angelo,
Rutgers University, New Brunswick, NJ. In all of the experiments with these
PLZFTg and PLZF+/− mice, WT littermate mice were used as a control. All animal
experiments were performed in accordance with the Institutional Animal Care
and Use Committee of the University of Michigan.
Cell Isolation and Purification. The single-cell suspensions from spleens were
prepared as per standard protocol (24). To sort NKT and CD4 T cells, splenocytes
were incubated in anti-CD19 beads (Miltenyi Biotec) in MACS buffer for 30 min
to exclude B cells, followed by passaging through MiniMACS columns (Miltenyi
Biotec) and collection of the flow through. NKT and CD4 T cells were sorted
using FACS Aria II/FACS Synergyhead1 (BD Biosciences). APC- or Pacific Blueconjugated murine CD1d tetramers loaded with PBS-57 were kindly provided
by the National Institute of Health Tetramer Facility, Atlanta, GA. For CD4
T cells enrichment, a positive selection enrichment kit was used according to the
manufacturer’s instructions (Miltenyi Biotec).
Cell Culture. To compare the responses of NKT and CD4 T cells after activation,
sorted cells were activated with plate bound anti-CD3 (2.5 μg/mL) and soluble
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anti-CD28 (1 μg/mL) antibodies (eBioscience) for an indicated time in the presence of IL-2 (10 U/mL) in RPMI medium 1640 supplemented with 10% FBS, 2 mM
glutamine, and penicillin/streptomycin at 37 °C. To study activated NKT cells
without involving CD4 T cells, we used α-GalCer (100 ng/mL). For the treatment
with 2-DG, Na-lactate, rapamycin, and oligomycin, NKT cells were stimulated
with soluble α-GalCer (100 ng/mL). For glucose and glutamine limitation
assay, sorted NKT and CD4 T cells were stimulated in glucose and glutaminefree RPMI 1640 media supplemented with 10% dialyzed FBS (Sigma Aldrich).
Flow Cytometry Assays. The following fluorescently conjugated antibodies
were used for surface and intracellular staining in the presence of anti-FcγR
mAb (2.4G2): anti-mouse TCR-β (H57-597) Pacific Blue/APC, PBS-57-loaded
CD1d tetramer APC/PE/Pacific Blue, anti-mouse CD4 (GK1.5) APC-Cy7, antimouse IFN-γ (XMG1.2) PE/FITC, anti-mouse IL-4 (BV D6-2462) PE-Cy7, and
anti-mouse IL-17 (TC11-18H10) PerCP-Cy5.5 (all from eBioscience).
For intracellular cytokine expressions, unstimulated or stimulated cells
were restimulated with 50 ng/mL of PMA (Sigma Aldrich) and 1.5 μM of
ionomycin (Sigma Aldrich) in the presence of Golgi Plug (BD Biosciences) for
4 h, followed by intracellular cytokine staining according to manufacturer’s
instruction (BD Biosciences). mTORC activity was measured using phospho-S6
Ribosomal protein (pS6Ser235/236) (Cell Signaling) and pAktSer473 (Cell Signaling) staining in permeabilization buffer. Cell death was measured by the
exclusion of propidium iodide (PI; 1 μg/mL) or live/dead Fixable Aqua Dead
Cell Stain (Invitrogen). Cells were acquired on FACS Canto II (BD Bioscience)
and data were analyzed using FlowJo (TreeStar software v9.9).
Mitochondrial Parameters Detection. To measure mitochondrial parameters,
total splenocytes (3 × 106 cells) or stimulated NKT and CD4 T cells (1 × 105)
cells were incubated with potentiometric dye TMRM (60 nM; Invitrogen),
MitoTracker green (30 nM; Invitrogen), and MitoSox (2.5 μM; Invitrogen) for
30 min at 37 °C in RPMI media for flow cytometry.
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Targeted Metabolites Measurements. Lysate was prepared from sorted NKT
and CD4 T cells (5 × 105 cells per replicate) by incubating the cells with 80%
methanol and following a series of vigorous mixing steps. Cells were spun
down at maximum speed to remove membranous debris, and the lysate was
collected for drying using a SpeedVac. Dried metabolites were collected and
analyzed using Agilent 6470 Triple Quadrupole LC-MS/MS metabolomics
with dynamic multiple reaction monitoring detection method.
Cell Proliferation. Sorted NKT and CD4 T cells were labeled with CellTrace
Violet (5 μM; Invitrogen) in 1× PBS containing 0.1% BSA for 30 min at 37 °C.
Cells were stimulated as indicated and analyzed by flow cytometry on day
3 of stimulation for CTV dilutions.
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Fig. 8. PLZF expression correlates with levels of OXPHOS. (A) CD4 T cells
from PLZFTg and WT littermate mice were enriched and stimulated as described in Materials and Methods for 3 d. The representative graph (Left)
shows the comparison of ECAR using the Seahorse assay. (Right) Graph
showing basal glycolysis, glycolytic capacity, and glycolytic reserve capacity in
PLZFTg and WT CD4 T cells from three independent experiments. (B) WT and
PLZFTg CD4 T cells were stimulated for 3 d, washed, and cultured in glucosefree RPMI containing glutamine (2 mM) and [13C6]-glucose (15 mM) for 4 h
before subjecting to LC-MS analysis. Representative graphs show the abundance of 13C6-glucose-derived carbon in glycolysis (F6P, 2PG, and lactate) and
TCA cycle (citrate, succinate, and malate) intermediate metabolites from
cells before (D0) and after stimulation for 3 d (D3). Two independent experiments showed similar results. Error bars represent mean ± SEM; ns, not
significant, *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.

Glucose Uptake Assay. For in vitro glucose uptake assay, total splenocytes (3 ×
106 cells) were incubated in 2-NBDG (20 μM; Invitrogen) for 1 h or as indicated at 37 °C in glucose-free RPMI 1640 media containing 10% dialyzed
FBS. For in vivo glucose uptake, mice were injected with 2-NBDG (100 μg per
mouse) intravenously. After 15 min of 2-NBDG injection, mice were killed,
and spleens were removed. Total splenocytes were stained for the surface
markers, as mentioned.
Glut1 Expression Detection. To study Glut1 expression, total splenocytes (3 ×
106 cells) were stained for surface markers and then fixed in 4% paraformaldehyde. The staining for the expression of Glut1 for flow cytometry was
performed at room temperature for 30 min in the dark using anti-Glucose
Transporter (Glut1) antibody (EPR3915; Abcam).
ATP and Lactate Assays. ATP levels were measured using CellTiter-Glo Luminescent Cell Viability reagent (Promega). For intracellular lactate level,
plate-based fluorometric measurement kit (excitation 530–540 nm, emission 585–
595 nm) was used according to the manufacturer’s instructions (Cayman Chemicals).
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incubated for 30 min in a non-CO2 incubator to equilibrate. ECAR was
measured in stimulated CD4 T cells using glucose (10 mM; Sigma Aldrich),
oligomycin (2 mM, ATP coupler; Sigma Aldrich), and 2-DG (100 mM; Sigma
Aldrich) in Seahorse assay medium using Seahorse XFe96 bioanalyzer
(Agilent Technologies).

RT2 Gene PCR Array. Total RNA was isolated from unstimulated and stimulated NKT and CD4 T cells using RNeasy Plus mini kit (Qiagen) according to the
manufacturer’s instructions. RNA samples were transported to the University
of Michigan DNA Sequencing Core to perform the Glucose Metabolism PCR
Array, and gene array was performed using Mouse Glucose Metabolism RT2
Profiles PCR Array according to the manufacturer’s instructions (Qiagen)
using Applied Biosystem’s 7900HT Sequence Detection System. Fold-changes
were calculated from ΔCt values (gene of interest Ct value – an average of
all housekeeping gene Ct values) using the ΔΔCt method. Gene expression
of target genes was normalized to the average of the housekeeping genes
β-actin, β-2 microglobulin, and heat-shock protein 90.
L. monocytogenes Infection. L. monocytogenes expressing Ovalbumin (LMOva) strain 10403s (originally obtained from M. L. Gray, Montana State
University, Bozeman, MT) was a kind gift from Mary O’Riordan, University of
Michigan, Ann Arbor, MI. L. monocytogenes was grown in BHI broth media
and the bacteria were collected in a midlog phase for infection. C57BL/
6 mice were injected intraperitoneally with 105 or 107 CFU per mouse of LMOva in 200 μL of PBS or PBS alone. On day 2 of infection, bacterial burden
was enumerated from homogenized spleen using colony forming unit determination by culturing serially diluted samples on LB agar plates. Intracellular
cytokine expression and glucose uptake by NKT cells were measured as
described above.
Statistical Analysis. All of the graphs were prepared and data analyzed using
Prism software (Prism v7; Graphpad Software). For comparison among
multiple groups, data were analyzed using one-way ANOVA with the multicomparison post hoc test. For correlation determination, Spearman correlation was calculated. For comparison between two groups, unpaired and
paired Student t tests were used. P < 0.05 was considered statistically
significant.

Metabolic Seahorse Assay. CD4 T cells from WT and PLZFTg mice were enriched
from freshly prepared splenocytes and stimulated as indicated. In the
XF96 well microplate coated with polylysine, 5 × 105 cells per well were
plated in glucose-free Seahorse media (Sigma Aldrich) and the plate was
briefly spun to affix the cells to the bottom of the wells. The plate was then
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